Article
Current Understanding of CHIP's Immunobiological Footprint with A Focus on Gastrointestinal Disorders: A Review of the Literature.
Current oncology reports - 10 Jun 2026
Arora Kirti, Chowdhary Rishi, McNulty Rachel, Chowdhary Rahul, Aleyadeh Wesam, Patel Megh, Singh Abhay
Abstract excerpt
PURPOSEOF REVIEW: Clonal hematopoiesis of indeterminate potential (CHIP) is characterized by the age-associated expansion of hematopoietic stem and progenitor cells (HSPCs) bearing somatic mutations in genes such as DNMT3A, TET2, ASXL1, and JAK2, without overt cytopenias or hematologic malignancy. CHIP is increasingly understood as a systemic inflammatory condition that influences extra-hematopoietic organs....
Topics
Join the communities discussing this publication.
